Total Payments
$798.70
2024 Payments
$33.73
Companies
10
Transactions
26
Medicare Patients
689
Medicare Billing
$93,922
Payment Breakdown by Category
Food & Beverage$798.70 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $798.70 | 26 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Amgen Inc. | $273.73 | 4 | $0 (2020) |
| Novartis Pharmaceuticals Corporation | $189.91 | 5 | $0 (2018) |
| Janssen Pharmaceuticals, Inc | $119.19 | 3 | $0 (2020) |
| ABBVIE INC. | $78.28 | 5 | $0 (2024) |
| Mylan Specialty L.P. | $31.24 | 2 | $0 (2022) |
| Allergan, Inc. | $30.85 | 2 | $0 (2020) |
| AstraZeneca Pharmaceuticals LP | $29.30 | 2 | $0 (2020) |
| Bayer Healthcare Pharmaceuticals Inc. | $18.74 | 1 | $0 (2023) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $14.49 | 1 | $0 (2024) |
| Merck Sharp & Dohme Corporation | $12.97 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $33.73 | 2 | ABBVIE INC. ($19.24) |
| 2023 | $18.74 | 1 | Bayer Healthcare Pharmaceuticals Inc. ($18.74) |
| 2022 | $16.11 | 1 | Mylan Specialty L.P. ($16.11) |
| 2021 | $59.04 | 4 | AbbVie Inc. ($59.04) |
| 2020 | $49.74 | 4 | Amgen Inc. ($15.00) |
| 2019 | $172.10 | 3 | Amgen Inc. ($156.97) |
| 2018 | $13.83 | 1 | Novartis Pharmaceuticals Corporation ($13.83) |
| 2017 | $435.41 | 10 | Novartis Pharmaceuticals Corporation ($176.08) |
All Payment Transactions
26 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 05/17/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $19.24 | General |
| Category: GASTROENTEROLOGY | ||||||
| 02/23/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | TRADJENTA (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $14.49 | General |
| Category: DIABETES | ||||||
| 01/23/2023 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $18.74 | General |
| Category: Cardio-renal | ||||||
| 07/12/2022 | Mylan Specialty L.P. | Yupelri (Drug) | Food and Beverage | In-kind items and services | $16.11 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 11/08/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $16.00 | General |
| Category: NEUROSCIENCE | ||||||
| 08/21/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $12.89 | General |
| Category: NEUROSCIENCE | ||||||
| 08/21/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $11.82 | General |
| Category: NEUROSCIENCE | ||||||
| 05/26/2021 | AbbVie Inc. | DALVANCE (Drug) | Food and Beverage | In-kind items and services | $18.33 | General |
| Category: ANTI-INFECTIVE | ||||||
| 12/17/2020 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $15.00 | General |
| Category: Inflammation | ||||||
| 11/05/2020 | AstraZeneca Pharmaceuticals LP | BREZTRI AEROSPHERE (Drug) | Food and Beverage | In-kind items and services | $12.61 | General |
| Category: Respiratory | ||||||
| 07/15/2020 | Allergan, Inc. | DALVANCE (Drug) | Food and Beverage | In-kind items and services | $11.00 | General |
| Category: ANTI-INFECTIVE | ||||||
| 02/10/2020 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $11.13 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 07/08/2019 | Mylan Specialty L.P. | Yupelri (Drug), Perforomist | Food and Beverage | In-kind items and services | $15.13 | General |
| Category: Respiratory and Allergy | ||||||
| 05/15/2019 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $40.91 | General |
| Category: Cardiology | ||||||
| 03/27/2019 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $116.06 | General |
| Category: Cardiology | ||||||
| 08/09/2018 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $13.83 | General |
| Category: CARDIOVASCULAR | ||||||
| 12/11/2017 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $3.48 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/28/2017 | Janssen Pharmaceuticals, Inc | INVOKANA (Drug) | Food and Beverage | In-kind items and services | $98.27 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 10/23/2017 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $16.69 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/13/2017 | Amgen Inc. | Prolia (Biological) | Food and Beverage | In-kind items and services | $101.76 | General |
| Category: Endocrinology | ||||||
| 08/24/2017 | Janssen Pharmaceuticals, Inc | INVOKANA (Drug), XARELTO | Food and Beverage | In-kind items and services | $9.79 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 06/21/2017 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $6.96 | General |
| Category: CARDIOVASCULAR | ||||||
| 04/26/2017 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $88.29 | General |
| Category: CARDIOVASCULAR | ||||||
| 04/19/2017 | Allergan Inc. | LINZESS (Drug) | Food and Beverage | In-kind items and services | $19.85 | General |
| Category: GASTROENTEROLOGY | ||||||
| 03/01/2017 | Merck Sharp & Dohme Corporation | ASMANEX (Drug), BELSOMRA, DULERA | Food and Beverage | In-kind items and services | $12.97 | General |
| Category: RESPIRATORY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2022 | 2 | 58 | 60 | $115,918 | $8,377 |
| 2021 | 5 | 293 | 319 | $551,606 | $41,178 |
| 2020 | 5 | 338 | 404 | $651,259 | $44,367 |
Total Patients
689
Total Services
783
Medicare Billing
$93,922
Procedure Codes
12
All Medicare Procedures & Services
12 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99285 | Emergency department visit for life threatening or functioning severity | Facility | 2022 | 44 | 46 | $96,094 | $6,937 | 7.2% |
| 99284 | Emergency department visit for problem of high severity | Facility | 2022 | 14 | 14 | $19,824 | $1,440 | 7.3% |
| 99285 | Emergency department visit, problem with significant threat to life or function | Facility | 2021 | 146 | 158 | $330,062 | $24,859 | 7.5% |
| 99284 | Emergency department visit, problem of high severity | Facility | 2021 | 75 | 81 | $114,696 | $7,683 | 6.7% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2021 | 27 | 28 | $72,740 | $5,933 | 8.2% |
| 99283 | Emergency department visit, moderately severe problem | Facility | 2021 | 33 | 36 | $26,892 | $1,781 | 6.6% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 12 | 16 | $7,216 | $921.92 | 12.8% |
| 99285 | Emergency department visit, problem with significant threat to life or function | Facility | 2020 | 175 | 203 | $424,067 | $27,114 | 6.4% |
| 99284 | Emergency department visit, problem of high severity | Facility | 2020 | 85 | 89 | $126,024 | $8,333 | 6.6% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2020 | 24 | 24 | $64,560 | $4,331 | 6.7% |
| 99309 | Subsequent nursing facility visit, typically 25 minutes per day | Facility | 2020 | 12 | 44 | $3,740 | $2,653 | 70.9% |
| 99283 | Emergency department visit, moderately severe problem | Facility | 2020 | 42 | 44 | $32,868 | $1,936 | 5.9% |
About Dr. Thomas Kupferer, D.O
Dr. Thomas Kupferer, D.O is a Emergency Medicine healthcare provider based in Murphysboro, Illinois. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/07/2005. The National Provider Identifier (NPI) number assigned to this provider is 1437147089.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Thomas Kupferer, D.O has received a total of $798.70 in payments from pharmaceutical and medical device companies, with $33.73 received in 2024. These payments were reported across 26 transactions from 10 companies. The most common payment nature is "Food and Beverage" ($798.70).
As a Medicare-enrolled provider, Kupferer has provided services to 689 Medicare beneficiaries, totaling 783 services with total Medicare billing of $93,922. Data is available for 3 years (2020–2022), covering 12 distinct procedure/service records.
Ad
Practice Information
- Specialty Emergency Medicine
- Other Specialties Rural Health, Family Medicine
- Location Murphysboro, IL
- Active Since 10/07/2005
- Last Updated 06/27/2024
- Taxonomy Code 207P00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1437147089
Products in Payments
- ENTRESTO (Drug) $189.91
- Repatha (Biological) $156.97
- INVOKANA (Drug) $108.06
- Prolia (Biological) $101.76
- VRAYLAR (Drug) $40.71
- LINZESS (Drug) $39.09
- Yupelri (Drug) $31.24
- DALVANCE (Drug) $29.33
- Kerendia (Drug) $18.74
- FARXIGA (Drug) $16.69
- Otezla (Drug) $15.00
- TRADJENTA (Drug) $14.49
- ASMANEX (Drug) $12.97
- BREZTRI AEROSPHERE (Drug) $12.61
- XARELTO (Drug) $11.13
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.